Back to Search
Start Over
Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS.
- Source :
-
HemaSphere [Hemasphere] 2019 Mar 01; Vol. 3 (2), pp. e187. Date of Electronic Publication: 2019 Mar 01 (Print Publication: 2019). - Publication Year :
- 2019
-
Abstract
- Competing Interests: The authors have indicated they have no potential conflicts of interest to disclose.
Details
- Language :
- English
- ISSN :
- 2572-9241
- Volume :
- 3
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- 31723826
- Full Text :
- https://doi.org/10.1097/HS9.0000000000000187